FDA approves IPL device to manage dry eye disease
Patented Lumenis Optimal Pulse Technology (OPT) becomes the first IPL approved for management of dry eye disease due to MGD, and Lumenis launches OptiLight.
Explore Other Resources
Dry EyePeriorbital Muscle StimulationPress PublicationsPress ReleasesTreatment TypeVision Resource Hub
Dry EyePeriorbital Muscle StimulationPress PublicationsPress ReleasesTreatment TypeVision Resource Hub
Behind OptiLIFT’s Lid Laxity Innovation
Dry EyeNewsPeriorbital Muscle StimulationPress PublicationsTreatment TypeVision Resource Hub
Dry EyeNewsPeriorbital Muscle StimulationPress PublicationsTreatment TypeVision Resource Hub
Lumenis launches OptiLIFT for toning periorbital muscles
Dry EyePeriorbital Muscle StimulationPress PublicationsVision Resource Hub
Dry EyePeriorbital Muscle StimulationPress PublicationsVision Resource Hub
OptiLIFT in Action: Dr. Julie McLaughlin’s Experience with the New Device
PB-00038930 Rev A